BioNTech SE
BNTX· Nasdaq
BioNTech SE
- Last sale
- Oct 2, 2026 · +0.12%
- Market cap
- $24.51B
- 252.88M shares
- Filings
- 579
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | €2,869,900,000 | reported | |
| FY 2024 | 2024-12-31 | €2,751,100,000 | reported | |
| FY 2023 | 2023-12-31 | €3,819,000,000 | reported | |
| FY 2022 | 2022-12-31 | €17,310,600,000 | reported | |
| FY 2021 | 2021-12-31 | €18,976,700,000 | reported | |
| FY 2020 | 2020-12-31 | €482,300,000 | reported | |
| FY 2019 | 2019-12-31 | €108,600,000 | reported | |
| FY 2018 | 2018-12-31 | €127,575,000 | reported | |
| FY 2017 | 2017-12-31 | €61,598,000 | reported |
BioNTech SE · CIK 1776985 · Engraved from SEC EDGAR
